Health Care · Health Care Equipment
Abbott Laboratories ABT
$100.68+1.85 (+1.87%)delayed quote · as of 2026-07-17 20:57 UTC
Market cap
$175.4B
Previous close
$98.83
Volume
17.1M
52-week range
$81.97 – $137.49
Verdictconfidence 100% · high
Strong operator, priced for perfection.
3 of 5 dimensions score well; value and momentum flash caution.
Value402/5 checks
Growth603/5 checks
Quality804/5 checks
Health1005/5 checks
Momentum00/5 checks
Fair-value estimate $93.21 per share (2-stage FCF · individual beta · 10Y Rf 4.6%) — the price sits 8% above it.
Every check behind these scores — with its numbers, source, and evidence link — is in the workspace.
Key ratioslatest filing FY 2025
Value
P/E TTM
25.0
P/E NTM
16.3
EV/EBITDA
15.6
PEG
1.32
FCF yield
4.2%
Growth
Revenue 3y
+0.5%/yr
Revenue YoY
+5.7%
Expected EPS
+53.4%
Quality
Piotroski F
6 / 9
ROIC
ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-17 20:57 UTC · fundamentals FY 2025 · SEC EDGAR
Continue with ABT in ALAN
Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.
For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.